Schnitzler syndrome
Jump to navigation
Jump to search
Etiology
- acquired disorder associated with MGUS
Epidemiology
- 1% among patients with MGUS
Pathology
Clinical manifestations
- IgM monoclonal gammopathy
- chronic urticaria
- fever (75%)
- fatigue (75%)
- arthralgia (68%), bone pain (63%)
- night sweats (25%)
- lymphadenophathy (44%)
- hepatosplenomegaly
- peripheral neuropathy (54%)
* a long delay between the onset of symptoms & diagnosis, often up to 5 years, is common
Laboratory
- no diagnostic tests*
- complete blood count (CBC)
- serum protein electrophoresis
- IgM-kappa monoclonal gammopathy (94%)
Complications
- development of lymphoproliferative disease is rare
- may evolve into Waldenstrom's macroglobulinemia
Management
- interleukin 1-beta inhibitor[1]
- rilonacept
- canakinumab (Ilaris)
- anakira
More general terms
References
- ↑ 1.0 1.1 Jain T et al. Schnitzler syndrome: An under-diagnosed clinical entity. Haematologica 2013 Oct; 98:1581 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23812931 <Internet> http://www.haematologica.org/content/98/10/1581
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018